期刊文献+

盐酸曲马多胃漂浮缓释胶囊的制备 被引量:3

Preparation of Tramadol hydrochloride intragastric floating sustained-release capsule
下载PDF
导出
摘要 目的制备盐酸曲马多胃漂浮缓释胶囊(THIFSC),并研究其体外释药、持浮力随时间变化的情况。方法以正交设计优选处方,采用自制浮力测定仪测定THIFSC的持浮力在体外的变化,体外释药采用转篮法。结果所制THIFSC的体外释药符合Higuchi模型,体外至少可漂浮48h,漂浮6~55h时,净浮力几乎线性下降。结论所制备的THIFSC在体外持浮性能良好,释药行为具明显缓释特征。 OBJECTIVE To prepare Tramadol hydrochloride intra gastric floating sustained - release capsule( THIFSC), and investigate its in vitro release mechanism and floating capacity. METHODS Orthogonal experiment design was used to optimize the formulation. The buoyancy was determined by the buoyancy testing instrument made by ourselves, the in vitro dissolution was studied by cylindrical basket method. RESULTS The release profile of THIFSC in vitro fitted well by Higuehi model. THIFSC could maintain floating in vitro for at least 48 hours. From 6 to 55 hours buoyancy declined nearly lineally. CONCLUSION THIFSC possessed good floating and sustained -release property.
出处 《华西药学杂志》 CAS CSCD 北大核心 2007年第6期659-660,共2页 West China Journal of Pharmaceutical Sciences
关键词 盐酸曲马多 胃漂浮缓释胶囊 持浮力 体外释药 Tramadol hydrochloride Intragastrie floating sustained - release capsule Buoyancy In vitro dissolution
  • 相关文献

参考文献2

二级参考文献19

  • 1朱凤艳,吉中孚.氯氮平的药代动力学及其影响因素[J].临床精神医学杂志,1995,5(4):245-247. 被引量:6
  • 2Joseph NJ,Lakshmi S, Jayakrishnan A. A floating-type oral dosage form for piroxieam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits[J]. J Controlled Release, 2002,79(1-3) :71 - 79.
  • 3El-Kamel AH, Sokar MS, A1 Gamal SS, et al. Preparation and evaluation of ketoprofen floating oral delivery system[ J ].Int J Pharm ,2001,220(1-2) : 13 - 21.
  • 4Baumgartner S, Kristl J, Vrecer F, et al. Optimisation of floating matrix tablets and evaluation of their gastric residence time[J].Int J Pharm ,2000,195(1-2) : 125 - 135.
  • 5Li SF,Lin SS,Dagg BP, et al. Effect of HPMC and carbopol on the release and floating properties of gastric floating drug delivery system using factorial design[J].Int J Pharm ,2003,253(1-2) : 13 - 22.
  • 6Whitehead L,Collett JH, Fell JT. Amoxycillin release from a floating dosage form based on alginates[J].Int J Pharm,2000,210( 1-2):45 - 49.
  • 7Iannuccelli V, Coppi G, Bernabei MT, et al. Air compartment multiple-unit system for prolonged gastric residence. Part I.Formulation study[J].Int J Pharm, 1998,174(1-2) :47 - 54.
  • 8El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microeapsules for oral use: comparison with non-floating chitosan microspheres[J]. Int J Pharm, 2002,249(1-2) :7 - 21.
  • 9Sato Y, Kawashima Y, Takeuchi H, et al. In vitro and in vivo evaluation of rlboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans[J]. lnt J Pharm,2004,275(1-2) :97 - 107.
  • 10Streubel A, Siepmann J, Bodmeier R. Multiple unit gastroretentive drug delivery systems: a new p~eparation method for low density microparticles[J]. J Microencapsul, 2003,20 ( 3 ) : 329 - 347.

共引文献19

同被引文献20

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部